Y26-11151-20491
4 vaccinations
11 coded responses
37 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
4QV-19432-24565
Child or adolescent in my care · Male · 2021-07-31
GKJ-32505-52268
Child or adolescent in my care · Female · 2021-11-27
Timeline
-
2021-01-01
Registered in v-safe
-
2021-01-01
Dose 1 — Pfizer-BioNTech
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-08
- 2021-01-17
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tirednessFree text: SweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-05
- 2021-02-11
-
2021-02-18
Survey response — day 28, dose 2MedDRA: Diarrhoea, Fatigue, Nausea, Oropharyngeal pain — Feeling: FairFree text: Couple of days a sore throat, fatigue, nausea, loose stools.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-03-04
- 2021-04-23
- 2021-07-22
-
2021-11-27
Dose 3 — Pfizer-BioNTech
- 2021-11-27
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-29
Survey response — days 1–6 daily, dose 3MedDRA: Abdominal distension, Abdominal pain, Gastrointestinal disorder, Infrequent bowel movements, Wheezing — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Wheezing (and I don't have asthma), abdominal pain and unable to stool (normally stool daily, feels like an ileus with bloating/distinction)MedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-04
-
2021-12-13
Survey response — day 14, dose 3MedDRA: Fatigue, Night sweats — Feeling: FairFree text: Significant persistent fatigue since booster, not improved with sleeping average 9-10hrs past couple of weeks. Occasional night sweats.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — day 21, dose 3MedDRA: Fatigue, Headache, Myalgia — Feeling: FairFree text: Ongoing fatigue, intermittent headaches, muscle aches.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Survey response — day 28, dose 3MedDRA: Muscle fatigue — Feeling: GoodFree text: Muscle fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Survey response — day 35, dose 3MedDRA: Fatigue, Myalgia — Feeling: FairFree text: Continued severe muscle aches after exertion and daily fatigue despite sleeping 9-10 hours a night for two weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Survey response — day 42, dose 3MedDRA: Muscle fatigue, Pain — Feeling: GoodFree text: Ongoing Muscle fatigue and aches, especially after exertion.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-28
-
2022-05-31
Survey response — 6 months, dose 3MedDRA: Chest discomfort — Feeling: GoodFree text: Chest discomfort x 2 months.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Dose 4 — Pfizer-BioNTech
-
2022-11-02
Survey response — day 35, dose 4MedDRA: Chest discomfort, Wheezing — Feeling: FairFree text: Mild chest tightness, wheezingMedDRA releases: 2024-11 · check-in free text available
-
2022-12-27
Survey response — 3 months, dose 4MedDRA: Palpitations — Feeling: FairFree text: PalpitationsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-01 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-11-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Sweats
Release 4 — day 28, dose 2
Symptoms: Couple of days a sore throat, fatigue, nausea, loose stools.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Wheezing (and I don't have asthma), abdominal pain and unable to stool (normally stool daily, feels like an ileus with bloating/distinction)
Release 10 — day 14, dose 3
Symptoms: Significant persistent fatigue since booster, not improved with sleeping average 9-10hrs past couple of weeks. Occasional night sweats.
Release 10 — day 21, dose 3
Symptoms: Ongoing fatigue, intermittent headaches, muscle aches.
Release 10 — day 28, dose 3
Symptoms: Muscle fatigue
Release 10 — day 35, dose 3
Symptoms: Continued severe muscle aches after exertion and daily fatigue despite sleeping 9-10 hours a night for two weeks.
Release 10 — day 42, dose 3
Symptoms: Ongoing Muscle fatigue and aches, especially after exertion.
Release 11 — 6 months, dose 3
Symptoms: Chest discomfort x 2 months.
Release 12 — day 35, dose 4
Symptoms: Mild chest tightness, wheezing
Release 12 — 3 months, dose 4
Symptoms: Palpitations
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Muscle fatigue | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Abdominal distension | · | · | ✓ |
| SRO | Abdominal pain | · | · | ✓ |
| SRO | Gastrointestinal disorder | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Infrequent bowel movements | · | · | ✓ |
| SRO | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release